BeatO

What BeatO does

BeatO (Health Arx Technologies Pvt. Ltd.) is a New Delhi-based digital health platform founded in 2015 that targets India's diabetes and broader cardiometabolic patient population with an integrated device-plus-services stack. Its hardware line comprises smartphone-connected glucometers (BeatO CURV and BeatO Smart), a 15-day Bluetooth continuous glucose monitor, a FitScale smart scale, and integrated Omron blood pressure monitors, all funneling data into the BeatO mobile app which delivers AI-driven personalized insights. Around this hardware platform, BeatO operates subscription care programs (Diabetes Care Program with a 30-day free trial and a doctor-led GLP-1 Weight Loss Program) supported by 100+ doctors, 200+ health coaches, and consumables such as test strips, plus diabetes-friendly food and supplement brands (Balanz, GudSwap).

The company monetizes through a mix of one-time hardware sales, recurring device consumables, monthly care subscriptions, GLP-1 program fees, and e-commerce transactions on its own storefront (shop.beatoapp.com), with branded performance marketing and celebrity endorsement driving direct-to-consumer acquisition. Distribution leverages exclusive integrations with Omron (BP monitors) and Abbott (FreeStyle Libre CGM), and the company claims a patient base of 2M+ with 1M+ device users, supported by clinically validated outcomes (average HbA1c reduction of 2.16% in three months, 82.9% sugar control) and regulatory certifications including ISO 13485 and CDSCO approval. BeatO has raised approximately $47M across multiple rounds (Series B led by Lightrock India in Nov 2022), employs 251–500 staff, acquired Novique Health in 2021, and has begun international expansion into Singapore with broader ASEAN ambitions.

Name

BeatO

Legal name

Health Arx Technologies Pvt. Ltd.

Website

https://beatoapp.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

251–500 employees

Short description

BeatO is an India-based digital health platform that sells connected glucometers, CGMs, and BP monitors bundled with subscription diabetes and GLP-1 weight-loss care programs, serving over 2 million patients through its app and e-commerce channels.

Ownership category

akta.pro rank

Product category

Digital Diabetes Care

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLALAFAA

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)

Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

SECONDARYCRACAQAE

Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers)

Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

SECONDARYHLACAFAG

Medical-Grade Device Connectivity & Device Management (MDM)

Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

SECONDARYHLAHAHAJ

Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)

SECONDARYHLACAFAL

Connected Therapeutics & Smart Drug Delivery Monitoring

Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

• Diabetes care platform
• Digital health monitoring
• Continuous glucose monitoring
• Connected medical devices
• Weight loss program

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. Smart Devices Sales: Sale of IoT-connected medical devices including glucometers, CGM sensors, BP monitors, and smart scales. One-time hardware purchases with accompanying consumables (test strips, lancets).
2. Diabetes Care Program Subscription: Digital diabetes care program offering doctor consultations, health coaching, medicines for BP/cholesterol/diabetes, and ongoing monitoring. 30-day free trial followed by paid subscription.
3. GLP-1 Weight Loss Program: Doctor-led weight loss program with consultations, coaching, and GLP-1 medication. Consultation priced at ₹49 with ongoing program fees.
4. Food & Supplements: Sale of diabetes-friendly foods including low-GI staples, sugar-free snacks and drinks, ayurvedic supplements, vitamins, and protein products.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

BeatO operates a digital diabetes and cardiometabolic care platform that combines IoT-connected medical devices (smart glucometers, CGM sensors, BP monitors, smart scales) with a mobile app delivering AI-powered personalized insights, supported by doctor consultations, health coaching, and a 30-day free trial Diabetes Care Program. The company also offers a doctor-led GLP-1 Weight Loss Program and a line of diabetes-friendly foods and supplements under the Balanz brand, serving over 2 million patients in India.

Product overview

BeatO is India's most trusted platform for diabetes and GLP-1 weight loss management, operating as a digital care ecosystem with a platform-plus-modules architecture. The core platform centers on smartphone-connected glucometers (BeatO CURV, BeatO Smart), continuous glucose monitoring (BeatO CGM), and smart health devices (FitScale, Omron BP Monitor), all integrated through the BeatO mobile app. Supporting modules include the Diabetes Care Program (offering 30-day free trials with medicines, doctor support, and coaching), GLP-1 Weight Loss Program (doctor-led with medication and coaching), and a specialized Food & Supplements line featuring Low-GI staples, sugar-free products, and ayurvedic supplements. The ecosystem serves over 2 million patients with 10 lakh+ device users, 100+ doctors, and 200+ coaches, delivering clinically validated outcomes including average HbA1c reduction of 2.16%.

Differentiator

Problem solved

Functional benefit

Brands

• BeatO CURV: Smart glucometer with Bluetooth connectivity and Type-C USB connector for Android devices
• BeatO Smart
• BeatO CGM
• FitScale
• Balanz
• GudSwap

Products and services

• BeatO CGM 15-day Bluetooth-connected continuous glucose monitor with real-time glucose tracking (updates every minute), no scanning needed, easy one-push application, and personalized AI insights and trends. Targets diabetic patients seeking continuous monitoring.
• BeatO CURV Glucometer Smart glucometer with smartphone connectivity via Type-C USB, designed for Android devices. Includes AI-powered insights, lab-grade accuracy, auto-sync capabilities, free strips and lancets, and CDSCO approval.
• BeatO Smart Glucometer AI-powered glucometer compatible with iOS and Android via USB-C. Features auto-save readings, AI-powered health insights, lab-grade accuracy, ISO certification, and CDSCO approval. Includes 25 test strips and 25 lancets.
• FitScale Smart weighing scale with 18 body metrics that integrates with the BeatO app for comprehensive weight and health management tracking.
• Omron BP Monitor Blood pressure monitor from Omron (e.g., HEM-7140T1), fully integrated with the BeatO app via Bluetooth connectivity for combined diabetes and hypertension management. Sold as part of bundled offerings on BeatO's e-commerce platform.
• BeatO Diabetes Care Program Subscription-based diabetes care program offering a 30-day free trial that includes medicines for BP, cholesterol and diabetes, specialist doctor support, IIHMR certified diet coaches, and ongoing monitoring. Clinical studies show average HbA1c reduction of 2.16% within three months.
• GLP-1 Weight Loss Program Doctor-led weight loss program featuring highest quality GLP-1 medication, endocrinologist doctor support, IIHMR certified diet coaches, smart weighing scale included. Targets appetite and cravings with scientific approach. Initial doctor consultation at ₹49 with free coach support.
• Food & Supplements (Balanz) Specialty foods and supplements under the Balanz brand for health and sugar control, including Low-GI staples for everyday meals, sugar-free drinks and juices, diabetes-friendly snacks, and health supplements for glucose control.
• Ayurvedic Supplements Ayurvedic health supplements and juices for diabetes management, including products like Pure Himalayan Shilajit Resin for boosting energy, stamina and immunity.
• Glucometer Test Strips Test strips compatible with BeatO glucometers for blood glucose monitoring, available as part of device kits or sold separately as consumables.

Quantifiable outcome

• Average HbA1c reduction of 2.16% within 3 months of joining BeatO Diabetes Care Program
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• OmroncoreTechnology or IntegrationExclusive partnership for Omron BP monitors integrated with BeatO App. Omron devices (BP monitors) are Bluetooth-enabled and fully integrated with BeatO's digital platform for combined diabetes and hypertension management.
• AbbottcoreTechnology or IntegrationBeatO users can access Abbott Freestyle Libre CGM devices through the BeatO Diabetes Control program. This provides integrated CGM monitoring within BeatO's care ecosystem.

Scale indicators11 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Sugar.fit: India-based digital diabetes management platform offering CGM, coaching, and doctor consultations. Most direct comparable to BeatO in the Indian consumer diabetes care category, with similar D2C and subscription model.
• Fitterfly: India-based digital therapeutics company focused on diabetes, obesity, and cardiometabolic conditions with CGM-driven programs and coaching. Overlaps directly with BeatO's Diabetes Care and GLP-1 programs.
• Wellthy Therapeutics: India-based digital therapeutics platform for diabetes and cardiovascular disease management with AI-driven coaching. Direct competitor in the digital diabetes care segment where BeatO operates.
• Twin Health: AI-powered diabetes reversal platform operating in India and the US, using continuous monitoring and AI coaching. Comparable to BeatO in combining connected devices, AI insights, and a chronic care program.
• mySugr (Roche): Acquired by Roche, mySugr is a leading consumer diabetes app with connected glucometers and coaching globally. Direct comparable on app + device ecosystem; well-funded incumbent.
• Virta Health: US-based digital health company focused on type 2 diabetes reversal and weight loss using telehealth and remote monitoring. Comparable care model and outcomes-driven approach to BeatO's Diabetes Care Program.

Broad incumbents

• PharmEasy: Large Indian digital health platform offering medicine delivery, diagnostics, and telehealth. Broader scope than BeatO but overlaps in chronic care, devices, and online consultations; also an existing BeatO investor.
• Tata 1mg: India's leading online pharmacy and digital health platform (part of Tata Group) offering medicines, diagnostics, doctor consultations, and chronic care. Overlaps with BeatO's e-commerce and consultation offerings.
• Apollo Sugar: Apollo Hospitals' specialty diabetes care chain with clinics and digital programs across India. Competes with BeatO in diabetes care delivery, leveraging Apollo's hospital and clinical infrastructure.

Emerging players

• HealthifyMe: India-based AI-driven nutrition and fitness platform with a glucose management program (HealthifyPro). Partial overlap with BeatO on coaching, food/supplements, and metabolic tracking.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/beatoapp
• YouTubeyoutube.com/channel/UCdC7bX_jK9I9I7_8aK1Jf9Q
• Facebookfacebook.com/beatoapp
• LinkedInlinkedin.com/company/beatoapp
• Instagraminstagram.com/beatoapp

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds7 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BeatO